Promising development in the fight with cancer using artificial intelligence

Jan Seuntjens, PhD, is part of the MEDomics consortium and a member of the Cancer Research Program at the Research Institute of the...
August 10, 2021

New G protein inhibitor identified, with potential for cancer therapies

RI-MUHC team publishes study in Nature Communications describing a novel molecule that inhibits growth of cancer cells Published this week in Nature Communications,...
August 4, 2021

Prenatal exposure to viral infection may lead to transient neuropsychiatric disorders in adolescence

A new study conducted at the CoBrA Laboratory located in the Cerebral Imaging Centre at the Douglas Research Centre, sheds light on the...
August 3, 2021

RI-MUHC researchers contribute to global study of babies born with birth defects

A study published this month in The Lancet examined the risk of mortality for nearly 4,000 babies born with birth defects in 264...
August 3, 2021

Measuring creativity, one word at a time

People who are more creative can think of ideas with greater “distances” between them Can you think of three words that are completely...
July 27, 2021

Distinguished Toronto Scientist Dr. Jim Woodgett Takes Up Leadership of Terry Fox Research Institute on August 1

Vancouver, BC – The Board of Directors of the Terry Fox Research Institute (TFRI) announces the appointment of Jim Woodgett, a senior scientist...
July 26, 2021

RI-MUHC success in grant competition for transplantation research

Researchers awarded funds from the Canadian Donation and Transplantation Research Program for innovative research projects in organ and tissue transplantation Announced on July...
July 26, 2021

Scientists break record while battling antibiotic resistance

Drug-resistant diseases could cause up to 10 million deaths a year by 2050, according to the World Health Organization. Scientists used the Canadian...
July 26, 2021

RI-MUHC team identifies potential diagnostic biomarker for pancreatic cancer

Study demonstrates that regenerative protein 3A/3B promotes a newly recognized precursor of pancreatic cancer Published in Communications Biology, a new study by researchers...
July 26, 2021

How well do COVID-19 vaccines work in people with cancer, immune conditions and other populations of interest?

The Ottawa Hospital launches four national studies to find out, with $8M from Canada’s COVID-19 Immunity Task Force Researchers at The Ottawa Hospital...
July 26, 2021

STOPMTL.CA: First interactive map to self-report police stops in Montreal

Innovative open data research project to serve citizens and communities In 2019, an independent report commissioned by the City of Montreal demonstrated racial...
July 15, 2021

McGill team leads research advancing knowledge on rare inherited disorder & brain cell type

A rare inherited syndrome called Lesch-Nyhan Disease (LND) is caused by the tiniest of glitches – the deficiency of a single enzyme. It...
July 12, 2021